Sign In
Buy CANF
$3.15
-0.130 (-3.96%)
At Close: Jul 31, 2026
LD Micro - Announces Preliminary List of Presenters for the LD-500
01:00pm, Wednesday, 05'th Aug 2020
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin
Can-Fite Submits Investigational New Drug Application to U.S. FDA for COVID-19 Phase II Study
11:00am, Monday, 27'th Jul 2020
Can-Fite Submits Investigational New Drug Application to U.S. FDA for COVID-19 Phase II Study
Can-Fite Completes Development of an Assay to Identify Clinically Active Cannabis Derived Compounds
11:00am, Monday, 20'th Jul 2020
Can-Fite Completes Development of an Assay to Identify Clinically Active Cannabis Derived Compounds
Can-Fite Completes Phase II COVID-19 Protocol Based on FDA Guidance, Plans to File IND Shortly
11:00am, Wednesday, 15'th Jul 2020
Can-Fite Completes Phase II COVID-19 Protocol Based on FDA Guidance, Plans to File IND Shortly
Can-Fite Announces $3.4 Million Registered Direct Offering
12:00pm, Monday, 06'th Jul 2020
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today
Can-Fite Announces $8.0 Million Registered Direct Offering
12:00pm, Wednesday, 10'th Jun 2020
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today
Following Pre-IND Guidance From FDA Can-Fite To Advance Piclidenoson Into Phase II COVID-19 Trial In The US
11:04am, Tuesday, 09'th Jun 2020Following Pre-IND Guidance from FDA Can-Fite to Advance Piclidenoson into Phase II COVID-19 Trial in the U.S.
11:00am, Tuesday, 09'th Jun 2020
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announ
Can-Fite Participating in BIO Digital International Convention And One-on-One Partnering Meetings On June 8-12, 2020
11:26am, Monday, 08'th Jun 2020Can-Fite Participating in BIO Digital International Convention and One-on-One Partnering Meetings on June 8-12, 2020
11:25am, Monday, 08'th Jun 2020
Can-Fite Participating in BIO Digital International Convention and One-on-One Partnering Meetings on June 8-12, 2020
